Breaking News Instant updates and real-time market news.

2020-11-24 18:48:44 DKS Dick's Sporting $59.06 / +0.18 (+0.31%) 18:48 11/24/20 11/24 18:48 11/24/20 18:48	Dick's Sporting price target raised to $64 from $58 at Baird Baird analyst Peter Benedict raised the firm's price target on Dick's Sporting to $64 from $58 and keeps a Neutral rating on the shares after the company delivered "another blowout quarter." The analyst said that while the company will cycle steep compares in several categories, a recovery in team sports should represent a partial offset, and some drivers of this year's EBIT margin improvement seem structural.	24 Nov
DKS Dick's Sporting $59.06 / +0.18 (+0.31%) 11/10/20 Cowen Dick's Sporting weakness a buying opportunity, says Cowen 09/25/20 Cleveland Research Dick's Sporting upgraded to Buy from Neutral at Cleveland Research 08/27/20 Fly Intel: Top five analyst downgrades 08/27/20 Fly Intel: Top five analyst upgrades

2020-11-24 18:48:44

DKS

Dick's Sporting

$59.06 / +0.18 (+0.31%)

18:48

11/24/20

11/24

18:48

11/24/20

18:48

Dick's Sporting price target raised to $64 from $58 at Baird

Baird analyst Peter Benedict raised the firm's price target on Dick's Sporting to $64 from $58 and keeps a Neutral rating on the shares after the company delivered "another blowout quarter." The analyst said that while the company will cycle steep compares in several categories, a recovery in team sports should represent a partial offset, and some drivers of this year's EBIT margin improvement seem structural.

24
Nov

DKS Dick's Sporting

$59.06 / +0.18 (+0.31%)

11/10/20 Cowen: Dick's Sporting weakness a buying opportunity, says Cowen

09/25/20 Cleveland Research: Dick's Sporting upgraded to Buy from Neutral at Cleveland Research

08/27/20: Fly Intel: Top five analyst downgrades

08/27/20: Fly Intel: Top five analyst upgrades

TODAY'S FREE FLY STORIES

Hot Stocks	Cel Sci trading resumes 11:14 01/27/21 01/27 11:14 01/27/21 11:14 CVM CEL-SCI $17.00 / +2.46 (+16.92%) ShowHide Related Items >><< Company News Street Research Periodicals Options CVM CEL-SCI $17.00 / +2.46 (+16.92%) 11:09 Today Cel Sci trading halted, volatility trading pause 12/07/20 CEL-SCI announces update on Phase 3 cancer trial results 12/01/20 CEL-SCI's LEAPS peptides demonstrate clear survival benefit in COVID treatment 09/18/20 CEL-SCI awarded European patent for LEAPS vaccine in treatment of RA CVM CEL-SCI $17.00 / +2.46 (+16.92%) 05/14/20 H.C. Wainwright CEL-SCI price target raised to $23 from $18 at H.C. Wainwright CVM CEL-SCI $17.00 / +2.46 (+16.92%) 09/15/20 CEL-SCI a 'highly compelling short candidate,' MRC says in short report 09/15/20 CEL-SCI delay 'a smokescreen' to 'cover up' study failure, Feuerstein says CVM CEL-SCI $17.00 / +2.46 (+16.92%) 01/20/21 Largest borrow rate increases among liquid names 01/19/21 Largest borrow rate increases among liquid names 01/11/21 Cel Sci put volume heavy and directionally bearish 12/29/20 Cel Sci put volume heavy and directionally bearish
Recommendations	Vir collaboration gives H.C. Wainwright more confidence in COVID-19 program » 11:13 01/27/21 01/27 11:13 01/27/21 11:13 VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) , LLY Eli Lilly $208.50 / -4.4 (-2.07%) , GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) After Vir Biotechnology… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 11:04 Today Vir Biotechnology trading resumes 10:59 Today Vir Biotechnology trading halted, volatility trading pause 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail LLY Eli Lilly $208.50 / -4.4 (-2.07%) 07:30 Today AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail 01/26/21 Eli Lilly: Etesevimab, bamlanivimab reduced risk of Covid hospitalizations GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 08:32 Today Sanofi's priority is to continue to develop two Covid vaccine candidates 07:30 Today AbCellera-found antibody, bamlanivimab, to be developed with VIR-7831 for Covid 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 07:00 Today JPMorgan Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan 04:52 Today JPMorgan Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan 01/20/21 H.C. Wainwright Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright 12/24/20 Baird Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/26/21 Berenberg Eli Lilly data 'incrementally positive' for AbCellera, says Berenberg 01/20/21 Citi Citi opens 'positive Catalyst Watch' on Eli Lilly into Alzheimer's data 01/19/21 Roth Capital Merus price target raised to $32 from $19 at Roth Capital 01/19/21 Fly Intel: Top five analyst upgrades GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 01/26/21 Piper Sandler Amarin in 'strong position' against Health Net, says Piper Sandler 01/20/21 UBS GlaxoSmithKline price target raised to 1,450 GBp from 1,440 GBp at UBS 01/20/21 Fly Intel: Top five analyst downgrades 01/20/21 Credit Suisse GlaxoSmithKline downgraded to Underperform from Neutral at Credit Suisse VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 11/10/20 Vir Biotechnology reports Q3 EPS (67c), consensus (60c) 08/11/20 Vir Biotechnology reports Q2 EPS (27c), consensus (62c) LLY Eli Lilly $208.50 / -4.4 (-2.07%) 12/15/20 Eli Lilly sees FY21 EPS $7.75-$8.40, consensus $8.07 12/15/20 Eli Lilly raises FY20 EPS view to $7.45-$7.65 from $7.20-$7.40, consensus $7.32 12/02/20 Eli Lilly says updated purchase of LY-CoV555 to boost FY20 EPS view by 25c 10/27/20 Eli Lilly backs FY20 adj. EPS view $7.20-$7.40, consensus $7.28 GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 10/28/20 GlaxoSmithKline now sees 2020 adjusted EPS at lower end of down 1%-4% range 10/28/20 GlaxoSmithKline reports Q3 adjusted EPS 35.6p vs. 38.6p a year ago 10/08/20 GlaxoSmithKline sees impact of foreign exchange on Q3 sales of about 5% 07/29/20 GlaxoSmithKline reports Q2 adjusted EPS 19.2p, down 37% AER 08 Jul VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 08/23/20 Health officials hopeful monoclonal antibodies can treat Covid, WSJ reports LLY Eli Lilly $208.50 / -4.4 (-2.07%) 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says 11/20/20 Trump to release new rules aimed at lowering drug prices, WSJ reports GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 01/12/21 GSK looks to double blockbusters in portfolio by 2026, Bloomberg says 12/31/20 Drugmakers to hike U.S. prices on over 200 drugs, Reuters reports 12/23/20 Judge rules against White House drug pricing rule, Reuters says 12/11/20 GlaxoSmithKline offered $120 per share for Eidos Therapeutics, Bloomberg says VIR LLY GSK VIR Vir Biotechnology $114.48 / +37.99 (+49.67%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday 10/06/20 Fly Intel: Wall Street's top stories at midday LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/21/21 Fly Intel: Wall Street's top stories for Thursday 01/21/21 Fly Intel: Wall Street's top stories at midday 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/26/20 Week in review: How Trump's policies moved stocks 12/11/20 Fly Intel: Wall Street's top stories for Friday 12/11/20 Fly Intel: Wall Street's top stories at midday 01/26/21 Pharmacovigilance & Risk Management Strategies Virtual Conference 03/01/21 41st Annual Healthcare Virtual Conference 03/02/21 2021 London Global Healthcare Virtual Conference 01/29/21 Eli Lilly - LLY 02/03/21 GlaxoSmithKline - GSK LLY GSK LLY Eli Lilly $208.50 / -4.4 (-2.07%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th GSK GlaxoSmithKline $38.73 / -0.515 (-1.31%) 09/04/20 GlaxoSmithKline call volume above normal and directionally bullish 08/03/20 Unusually active option classes on open August 3rd 07/31/20 Unusually active option classes on open July 31st
Hot Stocks	Boeing sees 2021 revenue improving from 2020 » 11:12 01/27/21 01/27 11:12 01/27/21 11:12 BA Boeing $196.20 / -5.88 (-2.91%) Sees improvement in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $196.20 / -5.88 (-2.91%) 11:12 Today Boeing: 2021 to continue to be challenging, but sees upward trends from 2020 11:11 Today Boeing operating cash 'much improved' in 2021 vs. 2020 11:03 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 11:02 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA BA Boeing $196.20 / -5.88 (-2.91%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $196.20 / -5.88 (-2.91%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $196.20 / -5.88 (-2.91%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $196.20 / -5.88 (-2.91%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $196.20 / -5.88 (-2.91%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th
Hot Stocks	Boeing: 2021 to continue to be challenging, but sees upward trends from 2020 11:12 01/27/21 01/27 11:12 01/27/21 11:12 BA Boeing $196.25 / -5.83 (-2.88%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $196.25 / -5.83 (-2.88%) 11:11 Today Boeing operating cash 'much improved' in 2021 vs. 2020 11:03 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 11:02 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 10:55 Today Boeing CEO 'sure glad 2020 is in the rear-view mirror' BA Boeing $196.25 / -5.83 (-2.88%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $196.25 / -5.83 (-2.88%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $196.25 / -5.83 (-2.88%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $196.25 / -5.83 (-2.88%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $196.25 / -5.83 (-2.88%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th
Hot Stocks	Boeing operating cash 'much improved' in 2021 vs. 2020 11:11 01/27/21 01/27 11:11 01/27/21 11:11 BA Boeing $196.00 / -6.08 (-3.01%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $196.00 / -6.08 (-3.01%) 11:03 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 11:02 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 10:55 Today Boeing CEO 'sure glad 2020 is in the rear-view mirror' 10:48 Today Boeing: 787 deliveries to resume later this quarter, but none this month BA Boeing $196.00 / -6.08 (-3.01%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $196.00 / -6.08 (-3.01%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $196.00 / -6.08 (-3.01%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $196.00 / -6.08 (-3.01%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $196.00 / -6.08 (-3.01%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th

Conference/Events	Rimini Street to host virtual investor day » 11:11 01/27/21 01/27 11:11 01/27/21 11:11 RMNI Rimini Street $7.40 / -0.2 (-2.63%) Virtual Investor Day to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options RMNI Rimini Street $7.40 / -0.2 (-2.63%) 01/11/21 Rimini Street repurchases $15M of stock 10/01/20 Rimini Street appoints Michael Perica CFO 09/22/20 Green Cargo extends support agreement with Rimini Street for its SAP application 09/16/20 Rimini Street statement on court ruling on motions for partial summary judgement RMNI Rimini Street $7.40 / -0.2 (-2.63%) 10/02/20 Craig-Hallum Rimini Street initiated with a Buy at Craig-Hallum 08/06/20 Alliance Global Partners Rimini Street price target raised to $8.50 from $7.50 at Alliance Global Partners 07/28/20 Benchmark Benchmark starts Rimini Street at Buy with Oracle settlement in 'rearview' 07/28/20 Benchmark Rimini Street initiated with a Buy at Benchmark RMNI Rimini Street $7.40 / -0.2 (-2.63%) 11/05/20 Rimini Street raises FY20 revenue view to $321.5M-$322.5M from $314M-$320M 11/05/20 Rimini Street sees Q4 revenue $82.5M-$83.5M, consensus $81.99M 11/05/20 Rimini Street reports Q3 EPS (5c), consensus 7c 14 Aug RMNI Rimini Street $7.40 / -0.2 (-2.63%) 11/05/20 Fly Intel: After-Hours Movers 03/15/21 33rd Annual Roth Virtual Conference 02/01/21 Rimini Street, Inc. RMNI Rimini Street $7.40 / -0.2 (-2.63%) 11/30/20 Two new option listings and one option delisting on November 30th
Conference/Events	Taysha Gene Therapies management to meet virtually with William Blair » 11:09 01/27/21 01/27 11:09 01/27/21 11:09 TSHA Taysha Gene Therapies $29.80 / -1.2 (-3.87%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate On The Fly Events TSHA Taysha Gene Therapies $29.80 / -1.2 (-3.87%) 01/26/21 Taysha Gene Therapies appoints Timothy Douros as CLO, Tracy Porter as CPO 01/19/21 Taysha gets both rare pediatric disease and orphan drug designations for TSHA-10 01/04/21 Taysha Gene Therapies announces multi-year collaboration with AllStripes 12/21/20 Taysha announces that Ontario hospital received CTA approval from Health Canada TSHA Taysha Gene Therapies $29.80 / -1.2 (-3.87%) 01/04/21 Oppenheimer Taysha Gene Therapies initiated with an Outperform at Oppenheimer 10/19/20 Chardan Taysha Gene Therapies initiated with a Buy at Chardan 10/19/20 Jefferies Taysha Gene Therapies initiated with a Buy at Jefferies 10/19/20 Morgan Stanley Taysha Gene Therapies initiated with an Overweight at Morgan Stanley 24 Sep TSHA Taysha Gene Therapies $29.80 / -1.2 (-3.87%) 09/27/20 Opening Day: GoodRx rises over 50% in market debut 09/20/20 Opening Day: Snowflake shares double in biggest software IPO ever 02/01/21 Taysha Gene Therapies 02/02/21 Taysha Gene Therapies 02/03/21 Taysha Gene Therapies
Conference/Events	PDS Biotechnology management to meet virtually with Oppenheimer » 11:09 01/27/21 01/27 11:09 01/27/21 11:09 PDSB PDS Biotechnology $2.89 / -0.085 (-2.86%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Events PDSB PDS Biotechnology $2.89 / -0.085 (-2.86%) 01/14/21 PDS Biotechnology releases white paper on Versamune platform 01/06/21 PDS Biotechnology reports inducement grant under Nasdaq listing rule 12/21/20 PDS Biotechnology announces publication of study using Versamune-based vaccine 12/09/20 PDS Biotechnology appoints Seth Van Voorhees as CFO PDSB PDS Biotechnology $2.89 / -0.085 (-2.86%) 11/10/20 H.C. Wainwright PDS Biotechnology upgraded to Buy from Neutral at H.C. Wainwright 07/28/20 Alliance Global Partners PDS Biotechnology price target raised to $6.50 from $4 at Alliance Global 05/27/20 Alliance Global Partners PDS Biotechnology initiated with a Buy at Alliance Global Partners 03/30/20 H.C. Wainwright PDS Biotechnology downgraded to Neutral from Buy at H.C. Wainwright PDSB PDS Biotechnology $2.89 / -0.085 (-2.86%) 08/13/20 PDS Biotechnology reports Q2 EPS (19c), consensus (23c) 11 Aug 12 Feb 02/01/21 PDS Biotechnology 02/02/21 PDS Biotechnology
Hot Stocks	Cel Sci trading halted, volatility trading pause 11:09 01/27/21 01/27 11:09 01/27/21 11:09 CVM CEL-SCI $16.06 / +1.52 (+10.45%) ShowHide Related Items >><< Company News Street Research Periodicals Options CVM CEL-SCI $16.06 / +1.52 (+10.45%) 12/07/20 CEL-SCI announces update on Phase 3 cancer trial results 12/01/20 CEL-SCI's LEAPS peptides demonstrate clear survival benefit in COVID treatment 09/18/20 CEL-SCI awarded European patent for LEAPS vaccine in treatment of RA 09/15/20 CEL-SCI issue letter to shareholders regarding Multikine development program CVM CEL-SCI $16.06 / +1.52 (+10.45%) 05/14/20 H.C. Wainwright CEL-SCI price target raised to $23 from $18 at H.C. Wainwright CVM CEL-SCI $16.06 / +1.52 (+10.45%) 09/15/20 CEL-SCI a 'highly compelling short candidate,' MRC says in short report 09/15/20 CEL-SCI delay 'a smokescreen' to 'cover up' study failure, Feuerstein says CVM CEL-SCI $16.06 / +1.52 (+10.45%) 01/20/21 Largest borrow rate increases among liquid names 01/19/21 Largest borrow rate increases among liquid names 01/11/21 Cel Sci put volume heavy and directionally bearish 12/29/20 Cel Sci put volume heavy and directionally bearish
Syndicate	Shoals Technologies indicated to open at $26.50, IPO priced at $25 11:07 01/27/21 01/27 11:07 01/27/21 11:07 SHLS Shoals Technologies $0.00 / + (+0.00%) ShowHide Related Items >><< Syndicate 27 Jan

Conference/Events	Diginex management to meet virtually with Oppenheimer » 11:07 01/27/21 01/27 11:07 01/27/21 11:07 EQOS Diginex $15.70 / -0.83 (-5.02%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Events EQOS Diginex $15.70 / -0.83 (-5.02%) 01/25/21 Diginex enters strategic partnership with GSR Markets 12/17/20 Diginex to launch first derivative Bitcoin perpetual futures product this month 10/05/20 Diginex reconstitutes board following Nasdaq listing 10/01/20 Diginex lists, begins trading on Nasdaq 02/01/21 Diginex 02/08/21 Diginex
Hot Stocks	Infosys becomes 'elite' service partner with Snowflake » 11:05 01/27/21 01/27 11:05 01/27/21 11:05 INFY Infosys $17.76 / -0.095 (-0.53%) , SNOW Snowflake $281.42 / -0.41 (-0.15%) Infosys (INFY) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options INFY SNOW INFY Infosys $17.76 / -0.095 (-0.53%) 01/26/21 Infosys partners with FourKites for supply chain visibility solutions 01/13/21 Infosys to purchase assets, onboard employees of Carter Digital 12/22/20 Daimler AG, Infosys announce long-term IT infrastructure partnership 12/14/20 Infosys announces strategic partnership with EPWater SNOW Snowflake $281.42 / -0.41 (-0.15%) 01/14/21 Snowflake announces partnership with Saturn Cloud for '100x faster' data science 01/14/21 Alteryx announces partnership with Snowflake 01/12/21 New Relic announces integration with Snowflake 01/12/21 FactSet announces expanded offering with Snowflake INFY SNOW INFY Infosys $17.76 / -0.095 (-0.53%) 01/14/21 Investec Infosys downgraded to Hold from Buy at Investec 12/21/20 Goldman Sachs Infosys resumed with a Conviction Buy at Goldman Sachs 10/15/20 BMO Capital Infosys price target raised to $18 from $13 at BMO Capital 10/15/20 Baird Infosys downgraded to Underperform from Neutral at Baird SNOW Snowflake $281.42 / -0.41 (-0.15%) 01/21/21 Goldman Sachs Snowflake initiated with a Neutral at Goldman Sachs 01/19/21 Rosenblatt Snowflake initiated with a Neutral at Rosenblatt 01/15/21 Credit Suisse Snowflake price target raised to $310 from $265 at Credit Suisse 01/13/21 Citi Snowflake price target raised to $325 from $300 at Citi INFY SNOW INFY Infosys $17.76 / -0.095 (-0.53%) 01/13/21 Infosys boosts FY21 revenue growth view to 4.5%-5% in constant currency 01/13/21 Infosys reports Q3 basic EPS 17c, consensus 15c 10/14/20 Infosys boosts FY21 revenue growth view to 2%-3% in constant currency 10/14/20 Infosys reports Q2 basic EPS 15c, consensus 14c SNOW Snowflake $281.42 / -0.41 (-0.15%) 12/02/20 Snowflake sees Q4 GAAP product revenue up 97%-103% from last year at $162M-$167M 12/02/20 Snowflake reports Q3 EPS ($1.01), consensus (26c) 12/02/20 Notable companies reporting after market close 16 Sep SNOW SNOW Snowflake $281.42 / -0.41 (-0.15%) 09/26/20 Western Digital could have plenty of upside, Barron's says 09/15/20 Snowflake IPO priced at $120 per share, CNBC reports SNOW SNOW Snowflake $281.42 / -0.41 (-0.15%) 01/13/21 Citi says sell Palantir on deceleration in growth, upcoming lockup expiry 01/03/21 Opening Day: Six IPOs to watch in 2021 12/15/20 Before the Move: Watch Snowflake into lockup expiration 12/11/20 Airline changes, another Tesla downgrade among today's top calls on Wall Street 03/11/21 Snowflake - SNOW INFY SNOW INFY Infosys $17.76 / -0.095 (-0.53%) 10/27/20 Largest borrow rate increases among liquid names SNOW Snowflake $281.42 / -0.41 (-0.15%) 01/07/21 Snowflake call volume above normal and directionally bullish 12/15/20 Unusually active option classes on open December 15th 12/02/20 Snowflake options imply 18.2% move in share price post-earnings 10/23/20 Unusually active option classes on open October 23rd
Options	Virgin Galactic call volume above normal and directionally bullish » 11:05 01/27/21 01/27 11:05 01/27/21 11:05 SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) 01/25/21 Virgin Galactic trading resumes 01/25/21 Virgin Galactic trading halted, volatility trading pause 01/21/21 Virgin Galactic's VMS Eve to conduct flight from Spaceport America 01/14/21 Virgin Galactic rises 15.2% SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) 01/19/21 Susquehanna Virgin Galactic downgraded to Neutral from Positive at Susquehanna 10/23/20 Fly Intel: Pre-market Movers 10/23/20 Goldman Sachs Virgin Galactic initiated with a Neutral at Goldman Sachs 09/28/20 Fly Intel: Top five analyst initiations SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) 11/05/20 Virgin Galactic reports Q3 EPS (34c), consensus (26c) 08/03/20 Virgin Galactic reports Q2 EPS (30c), consensus (26c) 06 Aug 03 Jun 20 May SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) 10/20/20 Chanos 'joking' when talking 'positively' about space companies, CNBC says SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) 12/21/20 Fly Insider: Net 1 UEPS, GrafTech among weeks notable insider trades 12/14/20 Fly Intel: Wall Street's top stories for Monday 12/14/20 Fly Intel: Wall Street's top stories at midday 12/14/20 Fly Intel: Pre-market Movers 02/25/21 Virgin Galactic - SPCE SPCE Virgin Galactic $47.87 / +5.78 (+13.73%) 01/26/21 Virgin Galactic call volume above normal and directionally bullish 01/14/21 Virgin Galactic call volume above normal and directionally bullish 01/12/21 Virgin Galactic call volume above normal and directionally bullish 12/24/20 Largest borrow rate increases among liquid names
Hot Stocks	Vir Biotechnology trading resumes 11:04 01/27/21 01/27 11:04 01/27/21 11:04 VIR Vir Biotechnology $108.87 / +32.38 (+42.33%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events VIR Vir Biotechnology $108.87 / +32.38 (+42.33%) 10:59 Today Vir Biotechnology trading halted, volatility trading pause 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail 01/26/21 Vir Biotechnology announces data from ongoing Phase 1 trial of VIR-3434 VIR Vir Biotechnology $108.87 / +32.38 (+42.33%) 07:00 Today JPMorgan Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan 04:52 Today JPMorgan Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan 01/20/21 H.C. Wainwright Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright 12/24/20 Baird Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data VIR Vir Biotechnology $108.87 / +32.38 (+42.33%) 11/10/20 Vir Biotechnology reports Q3 EPS (67c), consensus (60c) 08/11/20 Vir Biotechnology reports Q2 EPS (27c), consensus (62c) 08 Jul VIR Vir Biotechnology $108.87 / +32.38 (+42.33%) 08/23/20 Health officials hopeful monoclonal antibodies can treat Covid, WSJ reports VIR Vir Biotechnology $108.87 / +32.38 (+42.33%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday 10/06/20 Fly Intel: Wall Street's top stories at midday 03/01/21 41st Annual Healthcare Virtual Conference
Conference/Events	BNY Mellon management to meet virtually with Evercore ISI » 11:04 01/27/21 01/27 11:04 01/27/21 11:04 BK BNY Mellon $40.63 / -0.71 (-1.72%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events BK BNY Mellon $40.63 / -0.71 (-1.72%) 01/19/21 BNY Mellon to implement data management platform for Janus Henderson 01/13/21 BNY Mellon, Amundi announce strategic alliance 12/18/20 BNY Mellon to resume share buyback program in 1Q21 12/16/20 Guardian Capital to acquire BNY Mellon's Canadian wealth management business BK BNY Mellon $40.63 / -0.71 (-1.72%) 01/21/21 RBC Capital BNY Mellon price target raised to $49 from $43 at RBC Capital 01/21/21 Citi BNY Mellon earnings selloff a 'bit overdone,' says Citi 01/11/21 Citi BNY Mellon upgraded to Buy from Neutral at Citi 01/11/21 Citi BNY Mellon upgraded to Buy from Neutral at Citi BK BNY Mellon $40.63 / -0.71 (-1.72%) 01/20/21 BNY Mellon reports Q4 ex-items EPS 96c, consensus 91c 01/19/21 Notable companies reporting before tomorrow's open 01/19/21 Notable companies reporting before tomorrow's open 10/16/20 BNY Mellon reports Q3 EPS 98c, consensus 94c BK BNY Mellon $40.63 / -0.71 (-1.72%) 10/06/20 BNY Mellon, NCB Capital enter deal for expansion in Saudi Arabia, Bloomberg says 09/21/20 Global banks moved allegedly illegal funds, Reuters reports 09/21/20 JPMorgan, other banks moved large sums of illicit cash, ICIJ reports 08/26/20 BNY Mellon: Majority of employees can work remotely until Jan., Bloomberg says BK BNY Mellon $40.63 / -0.71 (-1.72%) 11/30/20 Apple upgrade, Slack downgrade among today's top calls on Wall Street 11/10/20 Square, Wayfair upgrades among today's top calls on Wall Street 09/21/20 Fly Intel: Wall Street's top stories for Monday 09/21/20 Fly Intel: Wall Street's top stories at midday 02/24/21 22nd Annual Virtual Financial Services Forum 02/01/21 BNY Mellon

Hot Stocks	Boeing's 737 MAX cleared for return to service by U.K.'s CAA » 11:03 01/27/21 01/27 11:03 01/27/21 11:03 BA Boeing $195.50 / -6.58 (-3.26%) The UK Civil Aviation… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $195.50 / -6.58 (-3.26%) 11:02 Today Boeing's 737 MAX cleared for return to service by U.K.'s CAA 10:55 Today Boeing CEO 'sure glad 2020 is in the rear-view mirror' 10:48 Today Boeing: 787 deliveries to resume later this quarter, but none this month 10:47 Today CEO sees liquidity in the market for customers, Boeing BA Boeing $195.50 / -6.58 (-3.26%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $195.50 / -6.58 (-3.26%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $195.50 / -6.58 (-3.26%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $195.50 / -6.58 (-3.26%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $195.50 / -6.58 (-3.26%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th
General news	Survey of Business Uncertainty Employment Growth data reported » 11:02 01/27/21 01/27 11:02 01/27/21 11:02 January Survey of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
General news	Survey of Business Uncertainty Sales Growth data reported » 11:02 01/27/21 01/27 11:02 01/27/21 11:02 January Survey of… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Hot Stocks	Boeing's 737 MAX cleared for return to service by U.K.'s CAA 11:02 01/27/21 01/27 11:02 01/27/21 11:02 BA Boeing $195.35 / -6.73 (-3.33%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $195.35 / -6.73 (-3.33%) 10:55 Today Boeing CEO 'sure glad 2020 is in the rear-view mirror' 10:48 Today Boeing: 787 deliveries to resume later this quarter, but none this month 10:47 Today CEO sees liquidity in the market for customers, Boeing 10:44 Today Boeing: Demand for narrow body jets to recover sooner than wide body BA Boeing $195.35 / -6.73 (-3.33%) 01/20/21 Fly Intel: Top five analyst upgrades 01/20/21 Berenberg Boeing upgraded to Hold from Sell at Berenberg 01/04/21 Fly Intel: Top five analyst downgrades 01/04/21 Baird Boeing elevated to Fresh Pick at Baird BA Boeing $195.35 / -6.73 (-3.33%) 07:30 Today Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $195.35 / -6.73 (-3.33%) 01/25/21 Boeing 737 MAX set to take flight in Europe this week, Reuters reports 01/13/21 Emirates President: Boeing 777X entry likely in 2023 or later, Reuters says 01/13/21 Boeing's drone unit to pay $25M to settle civil fraud allegations, WSJ reports 01/02/21 Congress overturns Trump veto on Defense bill, NPR reports BA Boeing $195.35 / -6.73 (-3.33%) 09:08 Today Fly Intel: Pre-market Movers 01/20/21 Netflix upgrades, Tesla target hike among today's top calls on Wall Street 01/11/21 Fly Intel: Wall Street's top stories for Monday 01/11/21 Fly Intel: Wall Street's top stories at midday 10:30 Today Boeing - BA BA Boeing $195.35 / -6.73 (-3.33%) 12/07/20 Early notable gainers among liquid option names on December 7th 12/03/20 Unusually active option classes on open December 3rd 12/02/20 Boeing call volume above normal and directionally bullish 11/19/20 Notable open interest changes for November 19th
Recommendations	Hydro One price target raised to C$32 from C$31 at National Bank » 11:00 01/27/21 01/27 11:00 01/27/21 11:00 HRNNF Hydro One $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HRNNF Hydro One $0.00 / + (+0.00%) 01/13/21 CIBC Hydro One price target raised to C$33 from C$32 at CIBC 11/10/20 Credit Suisse Hydro One price target raised to C$32 from C$28 at Credit Suisse 11/09/20 CIBC Hydro One price target raised to C$32 from C$31 at CIBC 11/09/20 RBC Capital Hydro One price target raised to C$32 from C$31 at RBC Capital

Recommendations	Fortis price target lowered to C$60 from C$61 at National Bank » 11:00 01/27/21 01/27 11:00 01/27/21 11:00 FTS Fortis $40.68 / -0.64 (-1.55%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Events FTS Fortis $40.68 / -0.64 (-1.55%) 09/23/20 Fortis targets 75% reduction in carbon emissions by 2035 09/23/20 Fortis announces five-year capital investment plan of $19.6B 09/23/20 Fortis raises quarterly dividend 5.8% 09/23/20 Fortis CEO Barry Perry to retire, David Hutchens to succeed FTS Fortis $40.68 / -0.64 (-1.55%) 10:37 Today Scotiabank Fortis price target lowered to C$61 from C$63 at Scotiabank 01/05/21 RBC Capital Fortis downgraded to Sector Perform from Outperform at RBC Capital 01/05/21 RBC Capital Fortis downgraded to Sector Perform from Outperform at RBC Capital 07/31/20 BMO Capital Fortis price target raised to C$59 from C$56 at BMO Capital 02/12/21 Fortis - FTS
Hot Stocks	Vir Biotechnology trading halted, volatility trading pause 10:59 01/27/21 01/27 10:59 01/27/21 10:59 VIR Vir Biotechnology $98.80 / +22.31 (+29.17%) ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events VIR Vir Biotechnology $98.80 / +22.31 (+29.17%) 06:49 Today Eli Lilly, Vir and GlaxoSmithKline announce collaboration 06:48 Today Eli Lilly, Vir, GlaxoSmithKline: First patient dosed in BLAZE-4 trail 01/26/21 Vir Biotechnology announces data from ongoing Phase 1 trial of VIR-3434 01/12/21 Gilead, Vir Biotechnology establish collaboration for chronic HBV VIR Vir Biotechnology $98.80 / +22.31 (+29.17%) 07:00 Today JPMorgan Vir Biotechnology downgraded to Underweight after 70% rally at JPMorgan 04:52 Today JPMorgan Vir Biotechnology downgraded to Underweight from Neutral at JPMorgan 01/20/21 H.C. Wainwright Vir Biotechnology price target raised to $125 from $100 at H.C. Wainwright 12/24/20 Baird Baird maintains 'profound skepticism' of Vir's COVID antibody after Lilly data VIR Vir Biotechnology $98.80 / +22.31 (+29.17%) 11/10/20 Vir Biotechnology reports Q3 EPS (67c), consensus (60c) 08/11/20 Vir Biotechnology reports Q2 EPS (27c), consensus (62c) 08 Jul VIR Vir Biotechnology $98.80 / +22.31 (+29.17%) 08/23/20 Health officials hopeful monoclonal antibodies can treat Covid, WSJ reports VIR Vir Biotechnology $98.80 / +22.31 (+29.17%) 01/26/21 Fly Intel: Wall Street's top stories for Tuesday 01/26/21 Fly Intel: Wall Street's top stories at midday 10/06/20 Fly Intel: Wall Street's top stories for Tuesday 10/06/20 Fly Intel: Wall Street's top stories at midday 03/01/21 41st Annual Healthcare Virtual Conference
Recommendations	Emera price target lowered to C$59 from C$62 at National Bank » 10:59 01/27/21 01/27 10:59 01/27/21 10:59 EMRAF Emera $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EMRAF Emera $0.00 / + (+0.00%) 09/24/20 Emera CEO Nancy Tower to retire in 2021 EMRAF Emera $0.00 / + (+0.00%) 09:45 Today Scotiabank Emera upgraded to Outperform on 'top-tier' growth at Scotiabank 05:15 Today Scotiabank Emera upgraded to Outperform from Sector Perform at Scotiabank 01/13/21 CIBC Emera price target lowered to C$57 from C$58 at CIBC 11/16/20 RBC Capital Emera price target raised to C$64 from C$63 at RBC Capital
Recommendations	Canadian Utilities price target lowered to C$35 from C$36 at National Bank » 10:59 01/27/21 01/27 10:59 01/27/21 10:59 CDUAF Canadian Utilities $0.00 / + (+0.00%) National Bank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CDUAF Canadian Utilities $0.00 / + (+0.00%) 01/13/21 CIBC Canadian Utilities price target lowered to C$36 from C$37 at CIBC 11/02/20 National Bank Canadian Utilities price target lowered to C$36 from C$38 at National Bank 10/30/20 BMO Capital Canadian Utilities price target lowered to C$35 from C$36 at BMO Capital 10/30/20 RBC Capital Canadian Utilities price target lowered to C$37 from C$38 at RBC Capital
Syndicate	Fortistar Sustainable Solutions opens at $10.36, IPO priced at $10 per unit » 10:58 01/27/21 01/27 10:58 01/27/21 10:58 FSSI Fortistar Sustainable Solutions $0.00 / + (+0.00%) Fortistar Sustainable… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial

Events

Earnings calls, analyst events, roadshows and more

Today at 11:30

2-Year FRN Note Auction Government Event
PB
Today at 11:30

Prosperity Bancshares - PB Conference Calls
MEEC
Today at 11:30

Midwest Energy Emissions - MEEC Conference Calls
HESM
Today at 12:00

Hess Midstream Partners - HESM Conference Calls
Today at 12:00

Consumer Goods/Services Industry Meetings
HOPE
Today at 12:30

Hope Bancorp - HOPE Conference Calls
APH
Today at 13:00

Amphenol - APH Conference Calls
CPF
Today at 13:00

Central Pacific - CPF Conference Calls
Today at 13:00

Sustainability & ESG Research Industry Meetings
Today at 14:00

Prospects for 2021 and Beyond Government Event

Virtual Evemt

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	EZGO X EZGO EZGO Technologies IPO Managers: Priced at: $4.00 2.8M Shares CRKN X CRKN Crown Electrokinetics Secondary Managers: Roth Capital, National Securities, Colliers Priced at: $4.50 4.15M Shares LPCN X LPCN Lipocine Spot Secondary Managers: Raymond James Priced at: $1.75 14.3M Shares SEEL X SEEL Seelos Therapeutics Spot Secondary Managers: BTIG Priced at: $2.05 15.244M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	SCPS X SCPS Scopus BioPharma IPO Managers: Benchmark, Joseph Gunnar Priced at: $9.00 1M Shares SHLS X SHLS Shoals Technologies IPO Managers: Goldman Sachs, JPMorgan, Guggenheim, UBS, Morgan Stanley, Barclays & Credit Suisse, Cowen, Oppenheimer Priced at: $25.00 77M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TIRX X TIRX Tian Ruixiang IPO Managers: Network 1 Financial Priced at: $4.00 3M Shares GRBK X GRBK Green Brick Secondary Managers: Barclays & Goldman Sachs Priced at: $20.95 6M Shares CBIO X CBIO Catalyst Biosciences Spot Secondary Managers: Piper Sandler, Raymond James Priced at: $5.75 8.7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DZSI X DZSI DZS Spot Secondary Managers: Stifel, Needham & B. Riley Securities Priced at: $14.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLUG X PLUG Plug Power Spot Secondary Managers: Morgan Stanley Priced at: $65.00 28M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PSNL X PSNL Personalis Spot Secondary Managers: Morgan Stanley, BofA, Citi & Cowen Priced at: $38.00 3.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial QUMU X QUMU Qumu Spot Secondary Managers: Craig-Hallum Priced at: $6.75 3.225M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	ERF X ERF Enerplus Spot Secondary Managers: RBC Capital & BMO Capital $3.37 28.75M Shares
Tues	No deals
Wed	AGFY X AGFY Agrify IPO Managers: Maxim & Roth Capital $8.00-10.00 5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial OCDX X OCDX Ortho Clinical IPO Managers: JPMorgan, BofA, Goldman Sachs, Barclays & Morgan Stanley, Citi, Credit Suisse, UBS, Evercore ISI, Piper Sandler, ING Bank, Macquarie, Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez, Seibert Williams $20.00-23.00 70M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VINP X VINP Vinci Partners Investments IPO Managers: JPMorgan, Goldman Sachs & BTG Pactual, Itau BBA, BofA, Credit Suisse, UBS $16.00-18.00 13.873M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial XM X XM Qualtrics IPO Managers: Morgan Stanley & JPMorgan, BofA, Barclays, Deutsche Bank, Goldman Sachs, HSBC, Citi, BMO Capital, Truist, Canaccord, Evercore ISI, JPMorgan, Oppenheimer, Piper Sandler, Raymond James, William Blair, Loop Capital, RMRZ, SEEL $27.00-29.00 50.4M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ZIM X ZIM ZIM Integrated IPO Managers: Citi, Goldman Sachs & Barclays, Jefferies, Clarksons Platou $16.00-19.00 17.5M Shares ASO X ASO Academy Sports Secondary Managers: Credit Suisse, JPMorgan, KKR & BofA $23.69 12M Shares CVAC X CVAC CureVac Secondary Managers: BofA, Jefferies & Evercore ISI, UBS, Guggenheim, Berenberg, Kempen & Co., $104.50 5M Shares SEER X SEER Seer Secondary Managers: JPMorgan, Morgan Stanley, BofA & Cowen $81.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SGRY X SGRY Surgery Partners Secondary Managers: JPMorgan & Jefferies, Barclays, KKR, Macquarie $31.30 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SRGA X SRGA Surgalign Secondary Managers: Piper Sandler, Cantor Fitzgerald & BTIG, Craig-Hallum, Lake Street $2.11 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	HMPT X HMPT Home Point Capital IPO Managers: Goldman Sachs, Wells Fargo, Morgan Stanley & UBS, Credit Suisse, JPMorgan, BofA, JMP Securities, Piper Sandler, Seelaus, SPC Capital, Wedbush, Zelman $19.00-21.00 12.5M Shares SEGR X SEGR Southeastern Grocers IPO Managers: BofA & Goldman Sachs, Deutsche Bank, BMO Capital, Truist, Wells Fargo $14.00-16.00 8.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TRIN X TRIN Trinity Capital IPO Managers: Keefe Bruyette, Wells Fargo & UBS, Janney Montgomery Scott, B. Riley Securities, Ladenburg, Compass Point $13.50-15.50 7.55M Shares CALT X CALT Calliditas Therapeutics Secondary Managers: Citi, Jefferies & Stifel, Kempen & Co.,, LifeSci Capital, Carnegie $31.20 4.5M Shares DCT X DCT Duck Creek Technologies Secondary Managers: Goldman Sachs, JPMorgan & BofA $52.85 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Dick's Sporting price target raised to $64 from $58 at Baird

TODAY'S FREE FLY STORIES

Get Full Fly Access